Envestnet Asset Management Inc. Acquires 26,208 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Envestnet Asset Management Inc. increased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 14.3% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 209,687 shares of the company's stock after buying an additional 26,208 shares during the quarter. Envestnet Asset Management Inc. owned 0.08% of HCA Healthcare worth $62,938,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Investidor Profissional Gestao de Recursos Ltda. bought a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $235,000. Dynamic Technology Lab Private Ltd purchased a new position in shares of HCA Healthcare during the 4th quarter valued at $540,000. Oarsman Capital Inc. increased its holdings in HCA Healthcare by 21.7% in the 4th quarter. Oarsman Capital Inc. now owns 286 shares of the company's stock worth $86,000 after acquiring an additional 51 shares during the last quarter. Resona Asset Management Co. Ltd. purchased a new stake in HCA Healthcare during the fourth quarter valued at about $17,370,000. Finally, Integrated Quantitative Investments LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $435,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of recent research reports. Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Robert W. Baird reiterated a "neutral" rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday. Bank of America reduced their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Finally, Morgan Stanley cut their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $381.67.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Trading Down 0.9 %

NYSE HCA traded down $3.09 during trading on Tuesday, hitting $337.53. 289,300 shares of the company's stock traded hands, compared to its average volume of 1,385,903. The firm has a market cap of $83.10 billion, a P/E ratio of 15.36, a PEG ratio of 1.10 and a beta of 1.48. The stock has a fifty day moving average of $327.61 and a two-hundred day moving average of $335.63. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the company earned $5.90 earnings per share. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's payout ratio is currently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.